RENAL FUNCTION OF AN EVEROLIMUS BASED THERAPY AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN MAINTENANCE RENAL TRANSPLANT RECIPIENTS: 2 YEAR FOLLOW-UP DATA OF THE APOLLO TRIAL

被引：0
|
作者：
Sommerer, Claudia
Rath, Thomas
Budde, Klemens
Haller, Hermann
Arns, Wolfgang
Scheidl, Stefan [1 ]
Vogel, Eva-Maria [1 ]
Witzke, Oliver
Reinke, Petra
机构：
[1] Novartis, Pharma, Nurnberg, Germany
来源：
TRANSPLANT INTERNATIONAL | 2011年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：180 / 180
页数：1
相关论文
共 50 条
  • [31] POST HOC SUBGROUP ANALYSIS OF ZEUS: OUTCOME ON RENAL FUNCTION, EFFICACY AND SAFETY IN LIVING-DONOR KIDNEY TRANSPLANT RECIPIENTS AFTER CONVERSION FROM A CALCINEURIN INHIBITOR TO AN EVEROLIMUS BASED REGIMEN: 5 YEAR FOLLOW-UP DATA
    Lehner, F.
    Budde, K.
    Suwelack, B.
    Arns, W.
    Wuethrich, R. P.
    Reinke, P.
    Muehlfeld, A.
    Eisenberger, U.
    Stahl, R.
    Porstner, M.
    Heller, K.
    Wolters, H. H.
    Witzke, O.
    Hauser, I. A.
    Sommerer, C.
    [J]. TRANSPLANT INTERNATIONAL, 2015, 28 : 58 - 58
  • [32] Post Hoc Subgroup Analysis of ZEUS: Outcome on Renal Function, Efficacy and Safety in Living-Donor Kidney Transplant Recipients After Conversion from a Calcineurin Inhibitor to an Everolimus Based Regimen: 5 Year Follow-Up Data
    Lehner, F.
    Budde, K.
    Wuethrich, R.
    Reinke, P.
    Arns, W.
    Muehlfeld, A.
    Eisenberger, U.
    Stahl, R.
    Heller, K.
    Witzke, O.
    Suwelack, B.
    Wolters, H.
    Hauser, I.
    Porstner, M.
    Sommerer, C.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [33] Three Year Follow Up of the Randomized SCHEDULE Trial With Everolimus Initiation and Early Withdrawal of Calcineurin Inhibitor Therapy in De Novo Heart Transplant Recipients - A Multicenter, Randomized Scandinavian Trial
    Andreassen, A. K.
    Andersson, B.
    Gustafsson, F.
    Eiskjaer, H.
    Radegran, G.
    Gude, E.
    Jansson, K.
    Solbu, D.
    Karason, K.
    Arora, S.
    Dellgren, G.
    Gullestad, I.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (04): : S129 - S130
  • [34] Conversion from a calcineurin inhibitor-based immunosuppressive regimen to everolimus in renal transplant recipients: Effect on renal function and proteinuria
    Morales, J.
    Fierro, A.
    Benavente, D.
    Zehnder, C.
    Ferrario, M.
    Contreras, L.
    Herzog, C.
    Buckel, E.
    [J]. TRANSPLANTATION PROCEEDINGS, 2007, 39 (03) : 591 - 593
  • [35] Everolimus With Reduced Calcineurin Inhibitor in Thoracic Transplant Recipients With Renal Dysfunction: A Multicenter, Randomized Trial
    Gullestad, Lars
    Iversen, Martin
    Mortensen, Svend-Aage
    Eiskjaer, Hans
    Riise, Gerdt C.
    Mared, Lena
    Bjortuft, Oystein
    Ekmehag, Bjorn
    Jansson, Kjell
    Simonsen, Svein
    Gude, Einar
    Rundqvist, Bengt
    Fagertun, Hans E.
    Solbu, Dag
    Bergh, Claes-Hakan
    [J]. TRANSPLANTATION, 2010, 89 (07) : 864 - 872
  • [36] Factors Affecting Renal Function Evolution after Conversion to Everolimus in Maintenance Renal Transplant Recipients
    Cicora, F.
    Gonzalez, I
    Arriola, M.
    Palti, G.
    Cambarieri, R.
    Acosta, F.
    Sedevich, G.
    Petrone, H.
    Giordani, C.
    Aleman, S.
    Agost Carreno, C.
    Otero, A. B.
    Massari, P.
    [J]. TRANSPLANTATION, 2012, 94 (10) : 835 - 835
  • [37] Renal function in renal or liver transplant recipients after conversion from a calcineurin inhibitor to sirolimus
    Backman, L
    Reisæter, AV
    Wramner, L
    Ericzon, BG
    Salmela, K
    Brattström, C
    [J]. CLINICAL TRANSPLANTATION, 2006, 20 (03) : 336 - 339
  • [38] A Randomized Trial of Everolimus Initiation and Calcineurin Inhibitor (CNI) Elimination in Stable Heart Transplant Recipients With Impaired Renal Function
    Derthoo, D.
    Van Caenegem, O.
    De Pauw, M.
    Nellessen, E.
    Duerinckx, N.
    Ciarka, A.
    Droogne, W.
    Van Cleemput, J.
    Belmans, A.
    Meyns, B.
    Vanhaecke, J.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : S14 - S14
  • [39] Improvement in renal function after everolimus introduction and calcineurin inhibitor reduction in maintenance thoracic transplant recipients: The significance of baseline glomerular filtration rate
    Arora, Satish
    Gude, Einar
    Sigurdardottir, Vilborg
    Mortensen, Svend Aage
    Eiskjaer, Hans
    Riise, Gerdt
    Mared, Lena
    Bjortuft, Oystein
    Ekmehag, Bjorn
    Jansson, Kjell
    Simonsen, Svein
    Aukrust, Pal
    Solbu, Dag
    Iversen, Martin
    Gullestad, Lars
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (03): : 259 - 265
  • [40] Calcineurin inhibitor-free immunosuppression using everolimus (Certican) in maintenance heart transplant recipients: 6 Months' follow-up
    Rothenburger, Markus
    Teerling, Elisa
    Bruch, Christian
    Lehmkuhl, Hans
    Suwelack, Barbara
    Bara, Christoph
    Wichter, Thomas
    Hinder, Frank
    Schmid, Christof
    Stypmann, Joerg
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (03): : 250 - 257
12345